Onconetix, Inc. Commitments, Fair Value Disclosure
Onconetix, Inc. (ONCO) had Commitments, Fair Value Disclosure of $10.00 thousand as of 2022-10-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:CommitmentsFairValueDisclosure · last filed 2023-03-09
- 2022-10-31: Commitments, Fair Value Disclosure $10.00K.
- 2022-10-09: Commitments, Fair Value Disclosure $264.00K.
- 2022-09-30: Commitments, Fair Value Disclosure $10.00K.
| Period end | Commitments, Fair Value Disclosure |
|---|---|
| 2022-10-31 | $10.00K 10-K · filed 2023-03-09 |
| 2022-10-09 | $264.00K 10-K · filed 2023-03-09 |
| 2022-09-30 | $10.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |